US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PIMCO DYNAMIC INCOME STRATEGY FUND

20.66

-0.2500-1.20%

Post-market: 20.660.00000.00%16:15 EDT

Volume:174.46K

Turnover:3.63M

Market Cap:923.65M

PE:3.89

High:21.25

Open:20.86

Low:20.65

Close:20.91

52wk High:25.21

52wk Low:18.47

Shares:44.71M

Float Shares:44.71M

Volume Ratio:1.65

T/O Rate:0.39%

Dividend:4.57

Dividend Rate:22.13%

EPS(TTM):5.31

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026

Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform

Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/PDX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDX\",,,,,undefined,":{"symbol":"PDX","market":"US","secType":"STK","nameCN":"PIMCO DYNAMIC INCOME STRATEGY FUND","latestPrice":20.66,"timestamp":1789588800000,"preClose":20.91,"halted":0,"volume":174460,"hourTrading":{"tag":"盘后","latestPrice":20.66,"preClose":20.66,"latestTime":"16:15 EDT","volume":9996,"amount":206517.36000000002,"timestamp":1789589700226,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.011956001912960305,"floatShares":44706949,"shares":44706949,"eps":5.31,"marketStatus":"Post-Mkt","change":-0.25,"latestTime":"09-16 17:25:38 EDT","open":20.86,"high":21.25,"low":20.65,"amount":3626686,"amplitude":0.028694,"askPrice":21.05,"askSize":1,"bidPrice":20.51,"bidSize":1,"shortable":3,"etf":0,"ttmEps":5.31,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"listingDate":1548824400000,"exchange":"NYSE","adjPreClose":20.91,"dividendRate":0.221268,"postHourTrading":{"tag":"盘后","latestPrice":20.66,"preClose":20.66,"latestTime":"16:15 EDT","volume":9996,"amount":206517.36000000002,"timestamp":1789589700226,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.65162},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDX\",,,,,undefined,":{"symbol":"PDX","floatShares":44706949,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.65162,"shares":44706949,"dividePrice":4.5714,"high":21.25,"amplitude":0.028694,"preClose":20.91,"low":20.65,"week52Low":18.47,"pbRate":"--","week52High":25.21,"institutionHeld":0,"latestPrice":20.66,"eps":5.31,"divideRate":0.221268,"volume":174460,"delay":0,"ttmEps":5.31,"open":20.86,"prevYearClose":18.78,"prevWeekClose":21.63,"prevMonthClose":21.82,"prevQuarterClose":20.82,"fiveDayClose":21.85,"twentyDayClose":21.73,"sixtyDayClose":20.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PDX\",params:#limit:5,,,undefined,":[{"date":"2026-09-11","symbol":"PDX","amount":0.1334,"announcedDate":"2026-09-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-11","defaultRemindTime":1789133400000,"name":"PIMCO DYNAMIC INCOME STRATEGY FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-01","payableDate":"2026-09-11","currency":"USD","dateTimestamp":1789099200000,"payDate":"2026-10-01"},{"date":"2026-08-13","symbol":"PDX","amount":0.1334,"announcedDate":"2026-08-03","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-13","defaultRemindTime":1786627800000,"name":"PIMCO DYNAMIC INCOME STRATEGY FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-01","payableDate":"2026-08-13","currency":"USD","dateTimestamp":1786593600000,"payDate":"2026-09-01"},{"date":"2026-07-13","symbol":"PDX","amount":0.1334,"announcedDate":"2026-07-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-13","defaultRemindTime":1783949400000,"name":"PIMCO DYNAMIC INCOME STRATEGY FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-03","payableDate":"2026-07-13","currency":"USD","dateTimestamp":1783915200000,"payDate":"2026-08-03"},{"date":"2026-06-11","symbol":"PDX","amount":0.1334,"announcedDate":"2026-06-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-11","defaultRemindTime":1781184600000,"name":"PIMCO DYNAMIC INCOME STRATEGY FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-01","payableDate":"2026-06-11","currency":"USD","dateTimestamp":1781150400000,"payDate":"2026-07-01"},{"date":"2026-05-11","symbol":"PDX","amount":0.1334,"announcedDate":"2026-05-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-11","defaultRemindTime":1778506200000,"name":"PIMCO DYNAMIC INCOME STRATEGY FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-01","payableDate":"2026-05-11","currency":"USD","dateTimestamp":1778472000000,"payDate":"2026-06-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-08","recordDate":"2023-12-11","paymentDate":"2024-01-02","value":0.22,"currency":"USD"},{"executeDate":"2024-03-08","recordDate":"2024-03-11","paymentDate":"2024-04-01","value":0.26,"currency":"USD"},{"executeDate":"2024-04-10","recordDate":"2024-04-11","paymentDate":"2024-05-01","value":0.1133,"currency":"USD"},{"executeDate":"2024-05-10","recordDate":"2024-05-13","paymentDate":"2024-06-03","value":0.1133,"currency":"USD"},{"executeDate":"2024-06-13","recordDate":"2024-06-13","paymentDate":"2024-07-01","value":0.1133,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PDX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2629830048","title":"Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2629830048","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629830048?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:00","pubTimestamp":1776855600,"startTime":"0","endTime":"0","summary":"Data showcase advances across oncology pipeline including pan-mutant BRAF, CBL-B and AURKA programs Presentations reinforce potential of degraders to overcome limitations of inhibitors and expand ther","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/22/3278794/0/en/Nurix-Therapeutics-Announces-New-Preclinical-Data-Highlighting-Breadth-of-Targeted-Protein-Degradation-Pipeline-at-AACR-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","PDX","BK4139","BK4135","NRIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629362056","title":"Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2629362056","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629362056?lang=en_us&edition=fundamental","pubTime":"2026-04-22 00:00","pubTimestamp":1776787200,"startTime":"0","endTime":"0","summary":"Presentation of additional analyses from FAP-Exd (AVA6103) study shows robust activity in PDX models with low FAP expression and more favorable kinetic profile compared to the marketed antibody-drug c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/21/3278250/0/en/Avacta-data-at-AACR-2026-underline-favorable-profile-of-AVA6103-and-advantages-of-pre-CISION-delivery-platform.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","LU0456854461.SGD","PDC","LU0266512127.USD","PK","BK4213","PDX","BK4123","BK4231","CRC","BK4218","BK4080","BK4181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628279482","title":"Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2628279482","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628279482?lang=en_us&edition=fundamental","pubTime":"2026-04-20 07:45","pubTimestamp":1776642300,"startTime":"0","endTime":"0","summary":"STRO-004 demonstrates robust and consistent antitumor activity across multiple TF-expressing solid tumor PDX models, with improved efficacy versus benchmark ADCs STRO-006 and STRO-227 show meaningful,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/19/3276676/0/en/Sutro-Biopharma-Presents-Promising-Preclinical-Data-Across-its-Pipeline-of-Next-Generation-Single-and-Dual-Payload-ADC-Programs-at-AACR-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","ADC","BK4080","BK4139","PDX","STRO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":23,"code":"91000000","status":"200"}]}}